Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease.

Autor: Fernando PMS; Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth, Western, Australia., Hooper AJ; Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth, Western, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia., Burnett JR; Department of Clinical Biochemistry, PathWest Laboratory Medicine WA, Royal Perth Hospital & Fiona Stanley Hospital Network, Perth, Western, Australia.; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.
Jazyk: angličtina
Zdroj: Expert opinion on investigational drugs [Expert Opin Investig Drugs] 2024 Jul; Vol. 33 (7), pp. 657-659. Date of Electronic Publication: 2024 May 08.
DOI: 10.1080/13543784.2024.2352129
Databáze: MEDLINE